Author:
Jain Nidhi,Weinstein Robert S.
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Liberman, U. et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N. Engl. J. Med. 333, 1437–1443 (1995).
2. Bone, H. G. et al. Dose-response relationships for alendronate treatment in osteoporotic elderly women. J. Clin. Endocrinol. Metab. 82, 265–274 (1997).
3. McClung, M. et al. Alendronate prevents postmenopausal bone loss in women without osteoporosis. Ann. Intern. Med. 128, 253–261 (1998).
4. Reid, I. R. et al. Alendronate in Paget's Disease. Am. J. Med. 101, 341–348 (1996).
5. Saag, K. G. et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N. Engl. J. Med. 339, 292–299 (1998).
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献